⌘K

Home/Filings/4/0001213900-22-009440

4//SEC Filing

Goodman Tony 4

Accession 0001213900-22-009440

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 3:05 PM ET

Size

12.5 KB

Accession

0001213900-22-009440

Insider Transaction Report

Form 4

Period: 2022-02-23

ADIAL PHARMACEUTICALS, INC.ADIL

DirectorChief Operating Officer

Transactions

Award
Stock Option
2022-02-23+40,000→ 40,000 total
Exercise: $2.00From: 2022-03-23Exp: 2032-02-22→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022.

Documents

2 files

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001717971

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 3:05 PM ET
Size: 12.5 KB

View on SEC.gov